CITRON TARGET INOVIO (INO) has neutralized the Citron distortion attack with positive data on its MERS vaccine, bolstered by CEPI funding! The two Citron attack pieces, almost universally considered bogus hit pieces designed to help Citron profit from shorting the stock - contain misleading and false information about INOVIO and its vaccine technology.
This week's data on its MERS vaccine validates the company's vaccine platform and strengthens the company's reports that it is CURING respiratory failure in COVID19 patients.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.